Alexandra Goll

Alexandra Goll

Director/Board Member at
Biovertis AG
70 year
Health Technology
Finance
Consumer Services

Profile

Ms. Alexandra Goll is General Partner at TVM Capital GmbH which she joined in 1998.
She is also Mitglied des Vorstands at Addex Pharmaceuticals SA. She is on the Board of Directors at Biovertis AG, Arrow Therapeutics Ltd., Cerenis Therapeutics Holding SA, and Albireo AB. Dr. Goll also served on the board at Pharmasset, Inc. Prior to her affiliation with TVM, Dr. Goll was the Global Business Leader for HIV and CMV, and was responsible for strategic marketing and business development for Virology at Roche Ltd. in Basel.
She had been involved in clinical development and managing commercialisation strategies of several products.
Dr. Alexandra Goll holds a degree in pharmacy from the Free University of Berlin, and wrote her doctoral dissertation in natural sciences at Philipps University of Marburg.

Alexandra Goll active positions

CompaniesPositionStart
Director/Board Member -

Former positions of Alexandra Goll

CompaniesPositionEnd
HEIDELBERG PHARMA AG Director/Board Member 14/12/2011
ADDEX THERAPEUTICS LTD Corporate Officer/Principal 17/04/2008
Director/Board Member 02/11/2007
IDENIX PHARMACEUTICALS INC Director/Board Member 01/05/2003
Corporate Officer/Principal -
See the detail of Alexandra Goll's experience

Training of Alexandra Goll

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

33

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Finance

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Alexandra Goll